Article

Robert Marc names KEM as agency of record

New York-Eyewear designer Robert Marc has appointed Ketchum Entertainment Marketing (KEM) as public relations agency for his collection of custom-made sun and eyewear. As part of its ongoing media relations and marketing campaigns, KEM will work to expand the brand's positioning with fashion and celebrity influences, consumer publications, and leverage product placement in film and television.

New York-Eyewear designer Robert Marc has appointed Ketchum Entertainment Marketing (KEM) as public relations agency for his collection of custom-made sun and eyewear. As part of its ongoing media relations and marketing campaigns, KEM will work to expand the brand's positioning with fashion and celebrity influences, consumer publications, and leverage product placement in film and television.

Marc said, "I have always strived to create the best and the most innovative eyewear, and was never afraid to do something different. KEM shares the same enthusiasm about presenting ideas in a novel way, and has the positioning expertise and relationships within the entertainment industry to help achieve our goals."

Mark Owens, KEM managing director, said, "With the abundance of eyewear on the market, it is important to remember that only a handful of people create the trends, and Robert Marc is a designer and company that has changed the face of what it means to wear glasses. We look forward to strengthening his reputation and driving consumer brand awareness."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.